Healthcare
McKesson Corporation(MCK)
Live Price
Offline$750.63
-3.74% today
1Y Change
+3.68%
Window
Jun 25, 2025 โ Jun 22, 2026
- Market Cap
- $99.71B
- Revenue Growth
- +16.2%
- EPS Growth
- +14.7%
- Dividend Yield
- 0.4%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
McKesson Corporation (MCK) is a Healthcare stock with a market cap of $99.71B and listed on NYSE. The stock last traded around $750.63 and up 3.7% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of +14.7%, a dividend yield of 0.4%. What stands out right now is revenue +16.2%, EPS +14.7%, free cash flow +44.1% with operating margin 1.3% and ROIC 24.0%. The dividend is present but secondary, with a yield around 0.4%. Valuation is more restrained than many high-expectation growth names at P/E 23.1 and price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines MCK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+16.2% vs +7.6% peer median
Operating Margin
Below sector median
+1.3% vs +19.4% peer median
P/E
Below sector median
23.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +16.2% and EPS at +14.7%, with operating margin around 1.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.4%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.8% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | -2.5% | -1.0% | +2.8% |
2026 Feb 4, 2026 | +1.9% | +16.5% | +16.0% | +13.3% |
2025 Nov 5, 2025 | +9.2% | +1.7% | -0.4% | -3.6% |
Benchmark Edge
MCK vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MCK
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MCK Max Drawdown
-27.17%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MCK and SPY.
Company Overview
McKesson Corporation
New York Stock Exchange
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Leadership
- Brian S. Tyler
- IPO Date
- Nov 10, 1994
- Employees
- 44.0k
- Street Address
- 6555 State Highway 161
- Mailing
- Irving, TX, 75039
- Region
- Irving, TX, US
- Reporting Currency
- USD
- Investor Line
- 972 446 4800
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 23.1
- EV/EBITDA
- 16.3
- Price/Sales
- 0.3
- Price/Book
- โ
Growth
- Revenue
- +16.2%
- EPS
- +14.7%
- Free Cash Flow
- +44.1%
Profitability
- Gross Margin
- 3.4%
- Operating Margin
- 1.3%
- Net Margin
- 1.1%
- ROE
- -245.3%
- ROIC
- 24.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.88
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.